Company intelligence / Profile preview

Novocap

Avellaneda, Buenos Aires, Argentinanovocap.com ↗

Ownership: Private
Employees: ~294
Development stage: Other

Overview

Novocap is a commercial-stage pharmaceutical company specializing in advanced drug delivery technologies such as controlled-release pellets and liquid-filled hard capsules. Their products are used in marketed drugs across multiple therapeutic areas. They offer contract development and manufacturing services to third parties.

Therapeutic areas: Men's HealthOncologyRheumatologyGastroenterologyCardiovascular
Modalities: Small moleculeLiquid-filled capsuleMicrogranule/microcapsule-based formulations
Industry: Biotech

Partnerships

Not specifically listed; provides CDMO services to various pharma clients.

Beyond the preview

Go deeper on Novocap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novocap.

Explore the full profile